Skip to main content
Article
Cefazolin and Carbapenem Combination to Treat Persistent Methicillin-sensitive Staphylococcus aureus Bacteremia in Preterm Infants
All Scholarly Works
  • Stefan Hagmann, Baystate Health
  • Taylor Hodle, Baystate Health
  • Maura Brennan, Baystate Health
  • Frank Szczerba, PharmD
  • Joanna Beachy, MD, Baystate Health
  • Evan Horton, Baystate Health
Document Type
Article, Peer-reviewed
Publication Date
10-1-2023
Abstract

Encouraged by bacteremia clearance using antistaphylococcal beta-lactams plus carbapenem combination in adults with refractory methicillin-sensitive Staphylococcus aureus infection, we present our experience with 2 preterm infants and review 1 previously published case. Noted successful bacteremia clearance in all 3 must be weighed against possible adverse effects associated with carbapenem use.

PMID
37922486
Citation Information
Hagmann SHF, Hodle T, Brennan M, Szczerba F, Camelo IY, Beachy J, Horton ER. Cefazolin and Carbapenem Combination to Treat Persistent Methicillin-sensitive Staphylococcus aureus Bacteremia in Preterm Infants. Pediatr Infect Dis J. 2023 Oct 27. doi: 10.1097/INF.0000000000004155. Epub ahead of print.